pharmafocusasia.com Report : Visit Site

Technical data of the pharmafocusasia.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host pharmafocusasia.com. Currently, hosted in India and its service provider is Iconic Designs .

the related websites

terrapinn.com ukpharmascan.org.uk blogs.barrons.com iconplc.com in-pharmatechnologist.com ennogen.com sigmaaldrich.com scopeophthalmics.com novonordisk.com smi-online.co.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

-- home editorial section strategy research & development clinical trials manufacturing information technology expert talk advertorials magazine client adverts -- previous issues forthcoming issue e-book archives foreword author guidelines advisory board editorial calendar testimonials e-newsletter subscribe archives -- knowledge bank articles interviews techno trends projects industry reports research insights book shelf case studies white papers industries updates news press releases events reports advertise print online target market target audience tech specs mediapack terms clientele subscribe webinars turkish airlines banner script end -- -- -- × webinar rapid, powerful techniques to address peptide mapping challenges in the biopharma industry register now -- -- -- -- how to develop a robust extractables & leachables program for your drug use of non-specific methods like toc for cleaning validation r&d; data hub - breaking silos to enable analytics advancing production capabilities to boost china’s pharmaceutical market integrated drug development strategy statin drug interactions and related adverse reactions managing clinical trial agreements stem cell and gene delivery drug concentration assurance of continuous tablet manufacturing pharmaceutical crystallisation hpapi qualification testing use of toc analysis in pharmaceutical industry the tip of the iceberg - how pipette tips influence assay results serving ergonomics: 3 steps to healthy working everyday culture practice - improving reproducibility in cell culture get instant access to latest e-book submit turkish airlines banner script end -- -- -- latest news read more... 05 jul 2018 theratechnologies submits novel single-vial formulation of egrifta® (tesamorelin for injection) for fda approval theratechnologies inc today announced that it has filed a supplemental new drug application snda with the food and drug administration fda for a singlevial formulation of egrifta the filing is based on bioequivalence studies which were completed earlier this year the new singlevial formulation known… 05 jul 2018 forendo pharma initiates phase i study for potential new, targeted treatment for endometriosis forendo pharma a drug development company focusing on novel oral treatments for endometriosis patients today announces it has received clinical trial authorisation cta from the uks medicines and healthcare products regulatory agency mhra to commence a study for its lead program for endometriosis is a… 04 jul 2018 fda approves xeomin® (incobotulinumtoxina) for adult patients with sialorrhea merz north america announced today that the us food and drug administration fda has approved the supplemental biologics license application sbla for xeomin incobotulinumtoxina for the treatment of chronic sialorrhea or excessive drooling in adult patients xeomin is the first and only neurotoxin with this… -- press releases read more... 05 jul 2018 boehringer ingelheim extends “one-stop-shop” service with new fill & finish capabilities in china boehringer ingelheim a leading contract manufacturer for biopharmaceutical medicines has rounded off its fullservice capabilities for customers with a new filling line at shanghai china with this latest extension the… 05 jul 2018 pharmaceutical filtration market to grow at 10.6% cagr by 2023: p&s; market research new york july globe newswire according to the market research report published by ps market research the pharmaceutical filtration market is expected to cross billion by growing at a cagr… 05 jul 2018 collplant appoints dr. wolfgang ruttenstorfer to its board of directors ness ziona israel july prnewswire collplant nasdaq clgn tase clgna regenerative medicine company utilizing its proprietary plantbased rhcollagen recombinant human collagen technology for tissue repair products today announced the appointment… events read more... 11-12 jul 2018 2nd annual international pharma supply chain confab 2018 active communications international - aci singapore 12-13 jul 2018 2nd eregulatory submissions summit exl events sonesta philadelphia rittenhouse square -- -- top articles 1 life-style, environment, and lack of prediabetes diagnosis fueling diabetic epidemic introduction for the past ten years ample evidence exists to suggest that what we eat and how we live determines how our body and genes behave a rapid rise i.. 2 cancer stem cell (csc) inhibitors cancer as a group of heterogeneous diseases very well known unimaginable amounts of money and manhours have been spent in finding cure for this deadly disease h.. 3 enhancement of the aqueous solubility and permeability of poorly water- soluble drugs introduction combinatorial chemistry high throughput screening technique hts and other computeraided methods have proved their usefulness for drug design and.. 4 blood-brain barrier and cns drug delivery introduction the idea of blood brain barrier bbb dates back to more than years ago when paul erlich observed that by intravenous injection of certain dyes all.. 5 nanocomposite hybrid metal-organic framework in drug delivery and theranostic application introduction mofs are evolving novel hybrid materials comprised of two component of inorganic and an organic fraction with diverse physicochemical characteris.. 6 nanotherapeutic intervention in cancer disease introduction cancer is second most prevalent and lethal disease after cardiovascular disorder despite of advances in tumor biology research and chemotherapy th.. knowledge bank interviews porton pharma solutions and codexis launch global partnership partnership codexis inc and porton pharma solutions ltd announce a strategic collaboration to deploy codexis worldleading biocatalyst technology within portons global custom intermediate and active pharmaceutical ingredients api development and manufacturing bus.. articles 3d cell culture technique introduction tumor cell culture as one of the vital technique utilised in tumor cell biology for estimation of potentiality of developed formulation or newly established chemical entity or therapeutics in cancer cell killing the two dimensional monolayer cell cultures has certain limitation of being identifying the incorrect architect microenvironment of d cultured cells growing… research insights clonal evolutionary analysis during her2 blockade in her2-positive inflammatory breast cancer: a phase ii open-label clinical trial of afatinib +/- vinorelbine abstract background inflammatory breast cancer ibc is a rare aggressive form of breast cancer associated with her amplification with high risk of metastasis and an estimated median survival of y we performed an openlabel singlearm phase ii clinical trial clinicaltrialsgov nct to investigate the efficacy and safety of afatinib an irreversible erbb family inhibitor alone and in combination with vinorelbine… case studies rapid, comprehensive, and aff ordable mycobacterial diagnosis with whole-genome sequencing: a prospective case study abstract background slow and cumbersome laboratory diagnostics for mycobacterium tuberculosis complex mtbc risk delayed treatment and poor patient outcomes wholegenome sequencing wgs could potentially provide a rapid and comprehensive diagnostic solution in this prospective study we compare realtime wgs with routine mtbc diagnostic workflows methods we compared… techno trends world's first mental-based probes for detection of dopamine receptors - developed by hkbu researchers a team of researchers of hong kong baptist university has developed the worlds first metalbased probes for the identification of dopamine receptors in living cells this breakthrough innovation helped the researchers to understand the dopamine receptors in carcinogenesis dopamine is an organic chemical of the catecholamine and phenethylamine which act as an important neurotransmitter in the central nervous system of… white papers launching global clinical trials—best practices for efficient and cost-effect

URL analysis for pharmafocusasia.com

https://www.pharmafocusasia.com/expert-talk
https://www.pharmafocusasia.com/terms
https://www.pharmafocusasia.com/knowledgebank
https://www.pharmafocusasia.com/magazine
https://www.pharmafocusasia.com/editorial-calendar
https://www.pharmafocusasia.com/projects
https://www.pharmafocusasia.com/banner/333
https://www.pharmafocusasia.com/banner/335
https://www.pharmafocusasia.com/articles/cancer-stem-cell-inhibitors
https://www.pharmafocusasia.com/reports/sanochemia-pharmazeutika-ag-sac-financial-and-strategic-swot-analysis-review
https://www.pharmafocusasia.com/news
https://www.pharmafocusasia.com/industryupdates
https://www.pharmafocusasia.com/articles/nanotherapeutic-intervention-in-cancer-disease
https://www.pharmafocusasia.com/casestudies
https://www.pharmafocusasia.com/pharma-reports

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: PHARMAFOCUSASIA.COM
Registry Domain ID: 126497363_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.google.com
Registrar URL: http://domains.google.com
Updated Date: 2017-06-16T04:16:37Z
Creation Date: 2004-08-05T09:10:58Z
Registry Expiry Date: 2018-08-05T09:10:58Z
Registrar: Google Inc.
Registrar IANA ID: 895
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.8772376466
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS-CLOUD-D1.GOOGLEDOMAINS.COM
Name Server: NS-CLOUD-D2.GOOGLEDOMAINS.COM
Name Server: NS-CLOUD-D3.GOOGLEDOMAINS.COM
Name Server: NS-CLOUD-D4.GOOGLEDOMAINS.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-03-13T01:17:25Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Google Inc.

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =pharmafocusasia.com

  PORT 43

  TYPE domain

DOMAIN

  NAME pharmafocusasia.com

  CHANGED 2017-06-16

  CREATED 2004-08-05

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS-CLOUD-D1.GOOGLEDOMAINS.COM 216.239.32.109

  NS-CLOUD-D2.GOOGLEDOMAINS.COM 216.239.34.109

  NS-CLOUD-D3.GOOGLEDOMAINS.COM 216.239.36.109

  NS-CLOUD-D4.GOOGLEDOMAINS.COM 216.239.38.109

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .